Mark Blake

Executive Director | Strategy and Corporate Development Leader | Board Member | Advisor | FinTech, Healthcare, Media

📍 New York City Metropolitan Area, United States🔄 Updated October 2026💼 5 investments📅 8 years investing🗓 Last invested Jul 2024
VC🌍 United States
5
Total investments
0
Early stage
3
Mid stage
0
Late stage
8y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2024
STAAR exists to raise critical funds for life-saving research for those with low-grade ovarian cancer. STAAR was co-founded by three low-grade ovarian cancer thrivers in early 2020. The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (less than 10% of ovarian cancer cases) and extremely underfunded subtype. Low-grade serous carcinoma is often labeled as a "tricky opponent" by clinicians because it acts differently than more common subtypes - it grows slower and is often chemo-resistant, leaving fewer treatment options. The average age of diagnosis is 18 years younger than ovarian cancer overall, meaning that many diagnosed are young moms or never got a chance to have children. Research dedicated to low-grade ovarian cancer is desperately needed to give women a chance at longer lives. ​For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
Board Member
Mar 2020
SCRIPTS Asia is the leading provider of Asia Pacific investor event coverage for the global institutional investment community. We specialize in regional event coverage through our unique ability to source events in local language, in-person attendance, and direct partnerships with corporates throughout Asia Pacific. To date, SCRIPTS Asia has a coverage universe of more than 1,100 regional equities across eight Asian markets: Japan, China, Hong Kong, Korea, Taiwan, Philippines, Thailand and Malaysia. SCRIPTS Asia content can be accessed directly through our API/FTP feed services, or through the SCRIPTS Asia web application. Our content is also available through leading terminal services such as: Nikkei Telecom, QUICK Corp., JPX, S&P Global Capital IQ, FactSet, Refinitiv, Aiera and Smartkarma. In addition, we are fully integrated in S&P Global's flagship product, Xpressfeed, empowering clients to seamlessly access our content through a feed. SCRIPTS Asia is aligned closely with the Nikkei Group and Tokyo Stock Exchange (JPX). We are also a member of the Securities Analyst Association of Japan (SAAJ), Japan Investor Relations Association, Hong Kong Investor Relations Association and the Investor Relations Professional Association of Singapore. For more information please refer to www.scriptsasia.com or contact us at sales@scriptsasia.com.
Board Observer
Aug 2018
FiscalNote (NYSE: NOTE) is the leading provider of AI-driven policy and regulatory intelligence solutions. By uniquely combining proprietary AI technology, comprehensive data, and decades of trusted analysis, FiscalNote helps customers efficiently manage political and business risk. Since 2013, FiscalNote has pioneered solutions that deliver critical insights, enabling effective decision making and giving organizations the competitive edge they need. Home to PolicyNote, CQ, Roll Call, VoterVoice, and many other industry-leading products and brands, FiscalNote serves thousands of customers worldwide with global offices in North America, Europe, and Asia. To learn more about FiscalNote and its suite of solutions, visit FiscalNote.com and follow @FiscalNote.
Experience · 10 entries
All (10)
Investments (5)
Board (5)
2024
Board Member
Jul 2024
STAAR exists to raise critical funds for life-saving research for those with low-grade ovarian cancer. STAAR was co-founded by three low-grade ovarian cancer thrivers in early 2020. The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (less than 10% of ovarian cancer cases) and extremely underfunded subtype. Low-grade serous carcinoma is often labeled as a "tricky opponent" by clinicians because it acts differently than more common subtypes - it grows slower and is often chemo-resistant, leaving fewer treatment options. The average age of diagnosis is 18 years younger than ovarian cancer overall, meaning that many diagnosed are young moms or never got a chance to have children. Research dedicated to low-grade ovarian cancer is desperately needed to give women a chance at longer lives. ​For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
2023
Consultant
Nov 2023
At Arbor Ventures we believe in lifes rich tapestry, nothing is too colourful or too bland. We are passionate about everything that we do. We connect our companies and entrepreneurs across the globe, we learn from each other to the benefit of all. We encourage innovation and support new discoveries and entrepreneurs.
2022
Advisory Board Member
Oct 2022
Investing in companies that, through science and technology, cultivate joy to improve the way we live.
2020
Board Member
Mar 2020
WhyHunger believes a world without hunger is possible. We provide critical resources to support grassroots movements and fuel community solutions rooted in social, environmental, racial and economic justice. We are working to end hunger and advance the human right to nutritious food in the U.S. and around the world.
Board Member
Mar 2020
SCRIPTS Asia is the leading provider of Asia Pacific investor event coverage for the global institutional investment community. We specialize in regional event coverage through our unique ability to source events in local language, in-person attendance, and direct partnerships with corporates throughout Asia Pacific. To date, SCRIPTS Asia has a coverage universe of more than 1,100 regional equities across eight Asian markets: Japan, China, Hong Kong, Korea, Taiwan, Philippines, Thailand and Malaysia. SCRIPTS Asia content can be accessed directly through our API/FTP feed services, or through the SCRIPTS Asia web application. Our content is also available through leading terminal services such as: Nikkei Telecom, QUICK Corp., JPX, S&P Global Capital IQ, FactSet, Refinitiv, Aiera and Smartkarma. In addition, we are fully integrated in S&P Global's flagship product, Xpressfeed, empowering clients to seamlessly access our content through a feed. SCRIPTS Asia is aligned closely with the Nikkei Group and Tokyo Stock Exchange (JPX). We are also a member of the Securities Analyst Association of Japan (SAAJ), Japan Investor Relations Association, Hong Kong Investor Relations Association and the Investor Relations Professional Association of Singapore. For more information please refer to www.scriptsasia.com or contact us at sales@scriptsasia.com.
Show all 10 entries ↓
Investment activity
2018–2024 · 5 investments
201822020220241
Recent (last 2 years)Earlier